Status:
COMPLETED
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
Lead Sponsor:
Aaron Chen
Collaborating Sponsors:
Thrasher Research Fund
Johns Hopkins University
Conditions:
Staphylococcal Infection
Abscess
Eligibility:
All Genders
6-18 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to help define the role of antibiotics in the treatment of pediatric skin infections caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). ...
Detailed Description
Community-associated methicillin resistant Staphylococcus Aureus (CA-MRSA) infections have increased significantly over the past decade. Nearly every major region of the country has reported infection...
Eligibility Criteria
Inclusion
- Children between the ages of 6 months and 18 years of age (inclusive)
- Suspected purulent staphylococcal skin or soft tissue infection
- No hospitalization within the previous 14 days
- Must have reliable means of follow-up contact (e.g. working phone)
- Outpatient management in the judgement of treating physician
Exclusion
- Hospitalization on initial visit
- Voluntary withdrawal by the treating physician in order to dictate the antibiotic being used
- Patients with a history of hypersensitivity to or intolerance of cephalexin (or other beta lactams) or clindamycin.
- Patients with altered immunity (inherited or acquired)
- Patients with skin infections related to surgical wounds or hardware.
- Patients currently on antibiotic therapy
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00352612
Start Date
September 1 2006
End Date
August 1 2009
Last Update
May 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21287